middle.news
Microba Doubles Revenue in Q2 FY25, Accelerates UK Market Entry
8:58am on Wednesday 29th of January, 2025 AEDT
•
Healthcare
Read Story
Microba Doubles Revenue in Q2 FY25, Accelerates UK Market Entry
8:58am on Wednesday 29th of January, 2025 AEDT
Key Points
Q2 FY25 revenue surged 102% to $4.43 million
MetaXplore test sales in Australia up 195% year-on-year
UK testing business gains momentum with early MetaXplore adoption
Therapeutic programs progressing, including Phase 2 trial for IBD
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Microba Life Sciences (ASX:MAP)
OPEN ARTICLE